| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
B Pathway in Airway Epithelium Impacts Host Defense against Pseudomonas aeruginosa1
,,
* Department of Veterans Affairs, Nashville, TN 37232;
Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine,
Department of Cancer Biology, and
Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; and
¶ Section of Pulmonary, Critical Care, and Sleep Medicine, University of Illinois, Chicago, Chicago, IL 60612
We investigated the impact of inflammatory signaling in airway epithelial cells on host defense against Pseudomonas aeruginosa, a major cause of nosocomial pneumonia. In mice, airway instillation of P. aeruginosa resulted in NF-
B activation in the lungs that was primarily localized to the bronchial epithelium at 4 h, but was present in a variety of cell types by 24 h. We modulated NF-B activity in airway epithelium by intratracheal delivery of adenoviral vectors expressing RelA (AdRelA) or a dominant inhibitor of NF-B before P. aeruginosa infection. Bacterial clearance was enhanced by up-regulation of NF-B activity following AdRelA administration and was impaired by treatment with a dominant inhibitor of NF-B. The TNF-
concentration in lung lavage was increased by AdRelA treatment and beneficial effects of NF-B up-regulation were abrogated in TNF--deficient mice. In contrast, NF-B inhibition reduced MIP-2 expression and neutrophil influx following P. aeruginosa infection. Therefore, inflammatory signaling through the NF-B pathway in airway epithelial cells critically regulates the innate immune response to P. aeruginosa.
This article has been cited by other articles:
|
|
 |
|
  C. G. Clement, S. E. Evans, C. M. Evans, D. Hawke, R. Kobayashi, P. R. Reynolds, S. J. Moghaddam, B. L. Scott, E. Melicoff, R. Adachi, et al. Stimulation of Lung Innate Immunity Protects against Lethal Pneumococcal Pneumonia in Mice Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1322 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Stathopoulos, A. Kollintza, C. Moschos, I. Psallidas, T. P. Sherrill, E. N. Pitsinos, S. Vassiliou, M. Karatza, S. A. Papiris, D. Graf, et al. Tumor Necrosis Factor-{alpha} Promotes Malignant Pleural Effusion Cancer Res., October 15, 2007; 67(20): 9825 - 9834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, F. Gigliotti, S. P. Bhagwat, S. B. Maggirwar, and T. W. Wright Pneumocystis stimulates MCP-1 production by alveolar epithelial cells through a JNK-dependent mechanism Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1495 - L1505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-s. Cheng, W. Han, S. M. Chen, T. P. Sherrill, M. Chont, G.-Y. Park, J. R. Sheller, V. V. Polosukhin, J. W. Christman, F. E. Yull, et al. Airway Epithelium Controls Lung Inflammation and Injury through the NF-{kappa}B Pathway J. Immunol., May 15, 2007; 178(10): 6504 - 6513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Mayer, M. Muehmer, J. Mages, K. Gueinzius, C. Hess, K. Heeg, R. Bals, R. Lang, and A. H. Dalpke Differential Recognition of TLR-Dependent Microbial Ligands in Human Bronchial Epithelial Cells J. Immunol., March 1, 2007; 178(5): 3134 - 3142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Haegens, T. F. Barrett, J. Gell, A. Shukla, M. MacPherson, P. Vacek, M. E. Poynter, K. J. Butnor, Y. M. Janssen-Heininger, C. Steele, et al. Airway Epithelial NF-{kappa}B Activation Modulates Asbestos-Induced Inflammation and Mucin Production In Vivo J. Immunol., February 1, 2007; 178(3): 1800 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Quinton, M. R. Jones, B. T. Simms, M. S. Kogan, B. E. Robson, S. J. Skerrett, and J. P. Mizgerd Functions and Regulation of NF-{kappa}B RelA during Pneumococcal Pneumonia J. Immunol., February 1, 2007; 178(3): 1896 - 1903. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
